Lv5
1590 积分 2024-02-28 加入
HELPER study: A phase II trial of continuous infusion of endostar combined with concurrent etoposide plus cisplatin and radiotherapy for treatment of unresectable stage III non-small-cell lung cancer
3天前
已完结
Oncolytic virus VG161 in refractory hepatocellular carcinoma
28天前
已完结
Recent advances in oncolytic virus therapy for hepatocellular carcinoma
28天前
已完结
Trastuzumab Plus Pertuzumab Versus Cetuximab Plus Irinotecan in Patients With RAS/BRAF Wild-Type, HER2-Positive, Metastatic Colorectal Cancer (S1613): A Randomized Phase II Trial
1个月前
已完结
Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial
1个月前
已完结
Neoadjuvant chemoradiation with or without PD-1 blockade in locally advanced rectal cancer: a randomized phase 2 trial
1个月前
已完结
Postoperative Radiotherapy ± Cetuximab for Intermediate-Risk Head and Neck Cancer
1个月前
已完结
Neo-adjuvant FOLFOX with and without panitumumab for patients with KRAS-wt locally advanced colon cancer: results following an extended biomarker panel on the FOxTROT Trial embedded phase II population
1个月前
已完结
Postoperative Radiotherapy ± Cetuximab for Intermediate-Risk Head and Neck Cancer
1个月前
已关闭
Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial
1个月前
已完结
皖公网安备34019202002308
